Latest Breaking News On - Auryon atherectomy - Page 2 : comparemela.com

Insider Buying: AngioDynamics, Inc (NASDAQ:ANGO) CEO Buys $67,000 00 in Stock

AngioDynamics, Inc. (NASDAQ:ANGO – Get Free Report) CEO James C. Clemmer purchased 10,000 shares of the firm’s stock in a transaction that occurred on Monday, April 8th. The shares were acquired at an average cost of $6.70 per share, for a total transaction of $67,000.00. Following the purchase, the chief executive officer now owns 539,066 […]

United statesJamesc clemmerRaymond jamesAngiodynamics incSecurities exchange commissionJpmorgan chase coFinancial services group incCommonwealth of pennsylvania public school empls retrmtMetlife investment managementRaymond james financial services advisors incGet free reportExchange commissionDynamics trading downJames financial services advisorsServices groupLife investment management

AngioDynamics (NASDAQ:ANGO) Lifted to Outperform at Oppenheimer

Oppenheimer upgraded shares of AngioDynamics (NASDAQ:ANGO – Free Report) from a market perform rating to an outperform rating in a report released on Friday morning, Marketbeat reports. Oppenheimer currently has $12.00 target price on the medical instruments supplier’s stock. A number of other analysts also recently issued reports on ANGO. Raymond James reduced their price […]

United statesRaymond jamesJamesc clemmerRaymond james financial services advisors incAngiodynamics company profileAngiodynamics incCommonwealth of pennsylvania public school empls retrmtJpmorgan chase coFinancial services group incMetlife investment managementFree reportModerate buyDynamics stock downGet free reportJames financial services advisorsServices group

Oppenheimer Upgrades AngioDynamics (NASDAQ:ANGO) to Outperform

Oppenheimer upgraded shares of AngioDynamics (NASDAQ:ANGO – Free Report) from a market perform rating to an outperform rating in a report released on Friday morning, Marketbeat Ratings reports. Oppenheimer currently has $12.00 price target on the medical instruments supplier’s stock. ANGO has been the subject of a number of other research reports. Raymond James decreased […]

United statesRaymond jamesJamesc clemmerSg capital managementAngiodynamics incAcadian asset managementAngiodynamics company profileJacobs levy equity management incBarclays plcFree reportMarketbeat ratingsModerate buyGet free reportAsset managementLevy equity managementAuryon atherectomy

AngioDynamics (NASDAQ:ANGO) Lifted to Outperform at Oppenheimer

Oppenheimer upgraded shares of AngioDynamics (NASDAQ:ANGO – Free Report) from a market perform rating to an outperform rating in a report issued on Friday, Marketbeat Ratings reports. Oppenheimer currently has $12.00 price target on the medical instruments supplier’s stock. A number of other brokerages have also recently weighed in on ANGO. Raymond James reduced their […]

United statesHong kongRaymond jamesHong kong ltdAngiodynamics incUs bancorpFree reportMarketbeat ratingsModerate buyGet free reportKong ltdFinancial advisorsGladius capital managementAuryon atherectomyAngiodynamics dailyNasdaq ango

Insider Buying: AngioDynamics, Inc (NASDAQ:ANGO) CEO Purchases 10,000 Shares of Stock

Insider Buying: AngioDynamics, Inc (NASDAQ:ANGO) CEO Purchases 10,000 Shares of Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongRaymond jamesJamesc clemmerAngiodynamics incHong kong ltdLazard asset managementUs bancorpGet free reportCapital managementKong ltdAuryon atherectomyAngiodynamics daily